Who owns GW Pharmaceutical?
Jazz Pharmaceuticals
GW Pharmaceuticals/Parent organizations
What did GW Pharmaceuticals close at today?
GW Pharmaceuticals Plc (GWPH)
| Prev Close | 219.28 |
|---|---|
| Open | 219.31 |
| Day Low/High | 218.60 / 219.54 |
| 52 Wk Low/High | 67.98 / 144.00 |
| Volume | 1.46M |
What company owns Epidiolex?
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) announced Wednesday plans to acquire U.K.-based GW Pharmaceuticals (NASDAQ: GWPH), which makes the cannabis-derived drug Epidiolex that is used to treat childhood-onset epilepsy.
Who owns Jazz Pharmaceuticals?
Bruce C. Cozadd
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003….Jazz Pharmaceuticals.
| Type | Public company |
|---|---|
| Headquarters | Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland |
| Area served | Worldwide |
| Key people | Bruce C. Cozadd (Chairman & CEO) |
Did Jazz Pharmaceuticals buy GWPH?
DUBLIN , May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
How expensive is Epidiolex?
GW’s cannabis-derived drug Epidiolex finally launches in the US with an average list price of $32,500.
How do I buy GW Pharmaceutical stock?
How to buy shares in GW Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details.
- Research the stock.
- Purchase now or later.
- Check in on your investment.
Did GW Pharmaceuticals get bought out?
Who are gwgw pharmaceuticals?
GW Pharmaceuticals is now part of Jazz Pharmaceuticals. GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics.
What are analysts’ target prices for GW Pharmaceuticals plc (GWP) stock?
12 brokerages have issued twelve-month target prices for GW Pharmaceuticals PLC-‘s shares. Their forecasts range from $185.00 to $238.00. On average, they expect GW Pharmaceuticals PLC-‘s stock price to reach $215.00 in the next year.
Does GW Pharmaceuticals stock pay dividends?
GW Pharmaceuticals does not currently pay a dividend. Dividend Growth. GW Pharmaceuticals does not have a long track record of dividend growth. Previous Next . 1.7 Company Ownership. Insider Buying vs. Insider Selling. In the past three months, GW Pharmaceuticals insiders have not sold or bought any company stock.
What is gwgw Pharmaceuticals plc’s (gwph) Q3 earnings report?
GW Pharmaceuticals plc (NASDAQ:GWPH) issued its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.63) by $0.27.